Ciprofloxacin in the treatment of pneumonia.
The use of ciprofloxacin as the sole agent in the treatment of 25 patients with pneumonias caused by susceptible organisms resulted in rapid cure. No side effects, superinfections, or recurrences were observed.
Furkejuvvon:
| Publikašuvnnas: | Antimicrob Agents Chemother |
|---|---|
| Váldodahkkit: | , , , , , |
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
American Society for Microbiology (ASM)
1986
|
| Fáttát: | |
| Liŋkkat: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180504/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2942104/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.6.1088 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|